Use of surface free energy for differential evaluation of crystal, crystal evaluated on basis of surface free energy as index, and pharmaceutical composition prepared by containing the crystal
AssigneesPola Pharma Inc., Nihon Nohyaku Co., Ltd.
InventorsTakaaki Masuda, Hideo Kaneda
Life of this patent
Estimating the term…
Abstract
An object is to provide means for suppressing the formation of any isomer of luliconazole on account of any influence of, for example, the humidity and the light and improving the stability. Disclosed is a method for differential evaluating a crystal of luliconazole, comprising differential evaluating the crystal by using, as indexes, surface free energy of the crystal of luliconazole and a ratio of a polar component of the surface free energy, wherein the crystal is evaluated to be stable on condition that the surface free energy is smaller and the ratio of the polar component is lower.
Claims2
A method for differential evaluation a crystal of luliconazole, comprising:
- evaluating the crystal by using, as indexes, surface free energy of the crystal of luliconazole and a ratio of a polar component of the surface free energy, wherein the crystal is evaluated as that formation rate of the z isomer is low and the crystal is suitable for a pharmaceutical preparation on condition that the surface free energy is not more than 28 mJ/m2 and the ratio of the polar component of the surface free energy is not more than 35%.
Dependencies are inferred from the claim text.